Salim Abdool Karim
#63,381
Most Influential Person Now
South African researcher
Salim Abdool Karim's AcademicInfluence.com Rankings
Salim Abdool Karimmedical Degrees
Medical
#865
World Rank
#1124
Historical Rank
Epidemiology
#181
World Rank
#193
Historical Rank
Salim Abdool Karimphilosophy Degrees
Philosophy
#4439
World Rank
#6950
Historical Rank
Logic
#1909
World Rank
#2778
Historical Rank
Download Badge
Medical Philosophy
Salim Abdool Karim's Degrees
- Masters Medicine University of KwaZulu-Natal
- PhD Epidemiology Columbia University
Why Is Salim Abdool Karim Influential?
(Suggest an Edit or Addition)According to Wikipedia, Salim S. Abdool Karim, MBChB, MMed, MS, FFPHM, FFPath , DipData, PhD, DSc, FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
Salim Abdool Karim's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women (2010) (2178)
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial (2002) (842)
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic (2021) (757)
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization (2021) (733)
- Timing of initiation of antiretroviral drugs during tuberculosis therapy. (2010) (728)
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies (2014) (675)
- Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia (2008) (610)
- Health in South Africa: changes and challenges since 2009 (2012) (564)
- HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response (2009) (561)
- Integration of antiretroviral therapy with tuberculosis treatment. (2011) (518)
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications (2021) (511)
- The Impact of Migration on HIV-1 Transmission in South Africa: A Study of Migrant and Nonmigrant Men and Their Partners (2003) (511)
- The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection (2011) (456)
- Genetic and Neutralization Properties of Subtype C Human Immunodeficiency Virus Type 1 Molecular env Clones from Acute and Early Heterosexually Acquired Infections in Southern Africa (2006) (379)
- SARS-CoV-2 variants and ending the COVID-19 pandemic (2021) (374)
- Achieving the health Millennium Development Goals for South Africa: challenges and priorities (2009) (360)
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women: Supporting Online Material (2010) (359)
- Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection (2007) (336)
- Genital inflammation and the risk of HIV acquisition in women. (2015) (313)
- Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women (2017) (307)
- SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection (2021) (298)
- Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape (2012) (296)
- HIV prevention transformed: the new prevention research agenda (2011) (295)
- Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants (2009) (270)
- Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load (2004) (243)
- Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection (2009) (240)
- Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women (2011) (236)
- Reducing the risk of HIV infection among South African sex workers: socioeconomic and gender barriers. (1995) (235)
- Defeating AIDS—advancing global health (2015) (232)
- Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic study. (2017) (227)
- Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women (2011) (221)
- Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study (2008) (214)
- Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression (2010) (209)
- Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants (2009) (207)
- Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes (2013) (196)
- Vertical T cell immunodominance and epitope entropy determine HIV-1 escape. (2012) (192)
- Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies (2015) (190)
- Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-Infected Individuals (2011) (190)
- Effect of removing user fees on attendance for curative and preventive primary health care services in rural South Africa. (2001) (187)
- Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. (2012) (186)
- The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection (2007) (182)
- Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells (2015) (180)
- Circular migration and sexual networking in rural KwaZulu/Natal: implications for the spread of HIV and other sexually transmitted diseases* (1997) (180)
- Migration and AIDS (1995) (178)
- Potent and Broad Neutralization of HIV-1 Subtype C by Plasma Antibodies Targeting a Quaternary Epitope Including Residues in the V2 Loop (2011) (173)
- Dual HIV-1 infection associated with rapid disease progression (2004) (172)
- Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary? (1998) (170)
- Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage (2008) (159)
- Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting (2011) (155)
- Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study (2014) (151)
- Innate immune activation enhances hiv acquisition in women, diminishing the effectiveness of tenofovir microbicide gel. (2012) (146)
- Seroprevalence of HIV infection in rural South Africa (1992) (144)
- Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic. (1999) (142)
- Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection (2016) (136)
- Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. (2003) (134)
- Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. (2004) (132)
- Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection (2007) (131)
- Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. (2011) (131)
- The Development of CD4 Binding Site Antibodies during HIV-1 Infection (2012) (129)
- Sexually Transmitted Infections Among Sex Workers in KwaZulu‐Natal, South Africa (1998) (120)
- Comparison of Viral Env Proteins from Acute and Chronic Infections with Subtype C Human Immunodeficiency Virus Type 1 Identifies Differences in Glycosylation and CCR5 Utilization and Suggests a New Strategy for Immunogen Design (2013) (119)
- Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. (2016) (117)
- Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies. (2014) (115)
- Reasons for lack of condom use among high school students. (1992) (112)
- Broad Neutralization of Human Immunodeficiency Virus Type 1 Mediated by Plasma Antibodies against the gp41 Membrane Proximal External Region (2009) (110)
- The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. (2003) (109)
- The Immune Reconstitution Inflammatory Syndrome After Antiretroviral Therapy Initiation in Patients With Tuberculosis: Findings From the SAPiT Trial (2012) (108)
- The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation (2019) (108)
- Global epidemiology of HIV-AIDS. (2007) (106)
- Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women (2003) (103)
- Antiretroviral prophylaxis: a defining moment in HIV control (2011) (101)
- Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy (2013) (98)
- Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly (2020) (95)
- Future scenarios for the COVID-19 pandemic (2021) (94)
- Association of HIV-Specific and Total CD8+ T Memory Phenotypes in Subtype C HIV-1 Infection with Viral Set Point1 (2009) (93)
- SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape (2022) (92)
- Estimating HIV incidence rates from age prevalence data in epidemic situations (2001) (91)
- Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women (2018) (90)
- Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge (2017) (90)
- Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. (2010) (89)
- The Lancet Commission on lessons for the future from the COVID-19 pandemic (2022) (88)
- Epidemiology: a research manual for South Africa (2007) (88)
- Anal sex and HIV transmission in women. (1998) (88)
- Beyond syndromic management: Opportunities for diagnosis-based treatment of sexually transmitted infections in low- and middle-income countries (2018) (87)
- Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection. (2015) (83)
- Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis. (2009) (82)
- A Pilot Study of Once-Daily Antiretroviral Therapy Integrated With Tuberculosis Directly Observed Therapy in a Resource-Limited Setting (2004) (81)
- Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. (2012) (79)
- Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2016) (78)
- Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection. (2008) (78)
- Association of TRIM22 with the Type 1 Interferon Response and Viral Control during Primary HIV-1 Infection (2010) (77)
- Teenagers seeking condoms at family planning services. Part I. A user's perspective. (1992) (77)
- The Impact of Incident and Prevalent Herpes Simplex Virus-2 Infection on the Incidence of HIV-1 Infection Among Commercial Sex Workers in South Africa (2005) (76)
- Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes (2018) (76)
- Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection (2018) (75)
- The South African Response to the Pandemic (2020) (74)
- Multiple Pathways of Escape from HIV Broadly Cross-Neutralizing V2-Dependent Antibodies (2013) (74)
- APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load (2010) (73)
- Duffy-null-associated low neutrophil counts influence HIV-1 susceptibility in high-risk South African black women. (2011) (73)
- Human Immunodeficiency Virus-Specific Gamma Interferon Enzyme-Linked Immunospot Assay Responses Targeting Specific Regions of the Proteome during Primary Subtype C Infection Are Poor Predictors of the Course of Viremia and Set Point (2008) (72)
- Bacterial Vaginosis and the Risk of Trichomonas vaginalis Acquisition Among HIV-1–Negative Women (2014) (71)
- Novel and Promiscuous CTL Epitopes in Conserved Regions of Gag Targeted by Individuals with Early Subtype C HIV Type 1 Infection from Southern Africa1 (2004) (68)
- Expert consensus statement on the science of HIV in the context of criminal law (2018) (68)
- HIV Incidence in Young Girls in KwaZulu-Natal, South Africa-Public Health Imperative for Their Inclusion in HIV Biomedical Intervention Trials (2012) (67)
- Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness (2015) (67)
- Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South Africa (2011) (66)
- Ability To Develop Broadly Neutralizing HIV-1 Antibodies Is Not Restricted by the Germline Ig Gene Repertoire (2015) (66)
- Changes in Natural Killer Cell Activation and Function during Primary HIV-1 Infection (2013) (66)
- Impact of on-site testing for maternal syphilis on treatment delays, treatment rates, and perinatal mortality in rural South Africa: a randomised controlled trial (2003) (64)
- Prevalence of HIV, HSV-2 and pregnancy among high school students in rural KwaZulu-Natal, South Africa: a bio-behavioural cross-sectional survey (2014) (63)
- Syndrome packets and health worker training improve sexually transmitted disease case management in rural South Africa: randomized controlled trial (2000) (63)
- Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research. (2018) (63)
- Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. (1999) (63)
- Isolation of a Monoclonal Antibody That Targets the Alpha-2 Helix of gp120 and Represents the Initial Autologous Neutralizing-Antibody Response in an HIV-1 Subtype C-Infected Individual (2011) (62)
- Case report: mechanisms of HIV elite control in two African women (2018) (61)
- Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity (2022) (61)
- The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis (2012) (61)
- The influence of AIDS stigma and discrimination and social cohesion on HIV testing and willingness to disclose HIV in rural KwaZulu-Natal, South Africa (2008) (60)
- Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection. (2009) (59)
- Sexually Transmitted Disease Syndromes in Rural South Africa: Results From Health Facility Surveillance (1998) (59)
- Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting (2017) (58)
- The prevalence and transmission of hepatitis B virus infection in urban, rural and institutionalized black children of Natal/KwaZulu, South Africa. (1988) (58)
- The evolving HIV epidemic in South Africa (2002) (57)
- Household clustering and intra-household transmission patterns of hepatitis B virus infection in South Africa. (1991) (56)
- Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months (2003) (56)
- Multidrug-resistant tuberculosis in patients without HIV infection. (1996) (56)
- Enrolling Adolescents in Research on HIV and Other Sensitive Issues: Lessons from South Africa (2006) (55)
- HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies (2018) (55)
- HIV incidence rates in adolescent girls and young women in sub-Saharan Africa. (2019) (55)
- Potential savings from generic prescribing and generic substitution in South Africa. (1996) (55)
- Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape (2017) (54)
- Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C gag Vaccine in Healthy HIV-1-Uninfected Adults (2012) (54)
- HIV infection and asymptomatic sexually transmitted infections in a rural South African community (1998) (53)
- Reasons for under-reporting of notifiable conditions. (1996) (53)
- HIV prevalence among high school learners - opportunities for schools-based HIV testing programmes and sexual reproductive health services (2012) (52)
- Maternal and child health indicators in a rural South African health district. (1997) (51)
- Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study (2022) (51)
- Trends in HIV Prevalence in Pregnant Women in Rural South Africa (2015) (50)
- Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial. (2020) (50)
- Patterns of infection: using age prevalence data to understand epidemic of HIV in South Africa (2000) (50)
- IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody (2019) (50)
- Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care (2004) (50)
- Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection (2015) (49)
- Epigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptor (2015) (49)
- Omicron infection enhances Delta antibody immunity in vaccinated persons (2022) (49)
- Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site. (2016) (49)
- Improving quality of sexually transmitted disease case management in rural South Africa (1998) (49)
- High Incidence of HIV‐1 in South Africa Using a Standardized Algorithm for Recent HIV Seroconversion (2002) (48)
- Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection (2021) (48)
- Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world (2000) (47)
- Relationship between female genital tract infections, mucosal interleukin‐17 production and local T helper type 17 cells (2015) (47)
- Risk Factors for HIV Acquisition in High Risk Women in a Generalised Epidemic Setting (2015) (47)
- Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection (2022) (46)
- When to start antiretroviral therapy during tuberculosis treatment? (2013) (46)
- Disclosure of Microbicide Gel Use to Sexual Partners: Influence on Adherence in the CAPRISA 004 Trial (2014) (45)
- Examination of attendance patterns before and after introduction of south africa's policy of free health care for children aged under 6 years and pregnant women (1997) (44)
- Screening for ‘window‐period’ acute HIV infection among pregnant women in rural South Africa (2010) (43)
- Rapid disease progression in HIV-1 subtype C-infected South African women. (2014) (42)
- A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. (2002) (42)
- Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis (2019) (42)
- Uptake of provider-initiated HIV testing and counseling among women attending an urban sexually transmitted disease clinic in South Africa – missed opportunities for early diagnosis of HIV infection (2010) (41)
- Sexual behaviour and knowledge of AIDS among urban black mothers. Implications for AIDS intervention programmes. (1991) (41)
- Overview of microbicides for the prevention of human immunodeficiency virus. (2012) (41)
- Clinical Severity of COVID-19 Patients Admitted to Hospitals in Gauteng, South Africa During the Omicron-Dominant Fourth Wave (2021) (40)
- Differential Impact of Magnitude, Polyfunctional Capacity, and Specificity of HIV-Specific CD8+ T Cell Responses on HIV Set Point (2013) (40)
- COVID-19 affects HIV and tuberculosis care (2020) (39)
- Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries. (2004) (39)
- Country profile. South Africa. (1997) (39)
- Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy (2019) (39)
- Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good. (2022) (39)
- HIV-1 Epidemic Control - Insights from Test-and-Treat Trials. (2019) (39)
- Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope (2017) (38)
- Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive. (2015) (37)
- High HIV Incidence and Prevalence Among Young Women in Rural South Africa: Developing a Cohort for Intervention Trials (2000) (37)
- Mechanisms of sexually transmitted infection‐induced inflammation in women: implications for HIV risk (2019) (36)
- A retrospective study of human immunodeficiency virus infection and drug-resistant tuberculosis in Durban, South Africa. (1997) (36)
- Inadequate Treatment for Sexually Transmitted Diseases in the South African Private Health Sector (1999) (36)
- Diagnostic Accuracy of the Point-of-Care Xpert HIV-1 Viral Load Assay in a South African HIV Clinic (2016) (36)
- HIV-1 Specific IgA Detected in Vaginal Secretions of HIV Uninfected Women Participating in a Microbicide Trial in Southern Africa Are Primarily Directed Toward gp120 and gp140 Specificities (2014) (36)
- The genital tract and rectal microbiomes: their role in HIV susceptibility and prevention in women (2019) (36)
- Low rifampicin concentrations in tuberculosis patients with HIV infection. (2014) (36)
- HIV-1 Epidemic Control - Insights from Test-and-Treat Trials. (2019) (35)
- Combination HIV prevention options for young women in Africa (2016) (35)
- Cervicovaginal Inflammation Facilitates Acquisition of Less Infectious HIV Variants (2017) (35)
- Contraceptive Choices, Pregnancy Rates, and Outcomes in a Microbicide Trial (2011) (35)
- The fate of free male condoms distributed to the public in South Africa (2001) (35)
- Antiretroviral prophylaxis for the prevention of HIV infection: future implementation challenges (2009) (34)
- Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial (2011) (34)
- An analysis of the cost of incomplete abortion to the public health sector in South Africa--1994. (1997) (34)
- Modeling the Impact of a Partially Effective HIV Vaccine on HIV Infection and Death Among Women and Infants in South Africa (2006) (33)
- Improved survival in multidrug-resistant tuberculosis patients receiving integrated tuberculosis and antiretroviral treatment in the SAPiT Trial. (2014) (33)
- Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. (2007) (33)
- HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women (2014) (32)
- Virological and Immunological Factors Associated with HIV-1 Differential Disease Progression in HLA-B*58:01-Positive Individuals (2011) (32)
- Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa. (2005) (32)
- Fluidity of HIV-1-Specific T-Cell Responses during Acute and Early Subtype C HIV-1 Infection and Associations with Early Disease Progression (2010) (31)
- A multinational Delphi consensus to end the COVID-19 public health threat (2022) (31)
- Vaginal insertion and douching practices among sex workers at truck stops in KwaZulu-Natal. (1998) (31)
- Loss of maternal measles antibody in black South African infants in the first year of life--implications for age of vaccination. (1991) (31)
- Vertical HIV transmission in South Africa: translating research into policy and practice (2002) (31)
- Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection (2022) (31)
- Adaptive changes in HIV-1 subtype C proteins during early infection are driven by changes in HLA-associated immune pressure. (2010) (31)
- Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant (2021) (30)
- Overcoming Impediments to Global Implementation of Early Antiretroviral Therapy (2015) (30)
- Stigma impedes AIDS prevention. (2011) (30)
- The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention (2011) (30)
- A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection (2012) (29)
- Accelerating the development of a safe and effective HIV vaccine: HIV vaccine case study for the Decade of Vaccines. (2013) (29)
- Safety of Tenofovir Gel, a Vaginal Microbicide, in South African Women: Results of the Caprisa 004 Trial (2013) (29)
- High prevalence of hepatitis B virus infection in rural black adults in Mseleni, South Africa. (1989) (28)
- The need for multipurpose prevention technologies in sub‐Saharan Africa (2014) (28)
- Availability of Condoms in Urban and Rural Areas of KwaZulu‐Natal, South Africa (2000) (28)
- A UNAIDS-Lancet Commission on Defeating AIDS—Advancing Global Health Defeating AIDS—advancing global health (2015) (28)
- Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site (2016) (27)
- Impact of an Adherence Intervention on the Effectiveness of Tenofovir Gel in the CAPRISA 004 Trial (2014) (27)
- HPV infection and the genital cytokine milieu in women at high risk of HIV acquisition (2019) (27)
- Incidence of Sexually Transmitted Infections Among HIV-Positive Sex Workers in KwaZulu-Natal, South Africa (2002) (27)
- Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemic (2021) (27)
- Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol (2017) (26)
- The South African Response to the Pandemic. (2020) (26)
- Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection (2014) (26)
- Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. (2015) (26)
- Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. (2011) (26)
- South Africa: host to a new and emerging HIV epidemic. (1999) (26)
- Metabolic Syndrome After HIV Acquisition in South African Women (2016) (26)
- Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa. (2007) (25)
- Acceptability of Early Antiretroviral Therapy Among South African Women (2018) (25)
- Adherence in the CAPRISA 004 Tenofovir Gel Microbicide Trial (2014) (25)
- AAV-Mediated Expression of Broadly Neutralizing and Vaccine-like Antibodies Targeting the HIV-1 Envelope V2 Region (2019) (25)
- HIV infection in high school students in rural South Africa: role of transmissions among students. (2014) (25)
- Changes to Antiretroviral Drug Regimens during Integrated TB–HIV Treatment: Results of the Sapit Trial (2014) (25)
- STD syndrome packets: improving syndromic management of sexually transmitted diseases in developing countries. (1999) (24)
- V2-Directed Vaccine-like Antibodies from HIV-1 Infection Identify an Additional K169-Binding Light Chain Motif with Broad ADCC Activity (2018) (24)
- Stigma impedes AIDS prevention (2011) (24)
- Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention: A Review (2020) (24)
- Temporal Association of HLA-B*81:01- and HLA-B*39:10-Mediated HIV-1 p24 Sequence Evolution with Disease Progression (2012) (24)
- Health-Related Quality of Life Dynamics of HIV-positive South African Women up to ART Initiation: Evidence from the CAPRISA 002 Acute Infection Cohort Study (2013) (24)
- Migrancy and HIV/STDs in South Africa--a rural perspective. (1997) (24)
- Trump's "global gag rule": implications for human rights and global health. (2017) (24)
- Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression (2011) (24)
- Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype (2015) (23)
- Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage (2015) (23)
- Trends in HIV Prevention, Treatment, and Incidence in a Hyperendemic Area of KwaZulu-Natal, South Africa (2019) (23)
- Treatment of maternal syphilis in rural South Africa: effect of multiple doses of benzathine penicillin on pregnancy loss (2004) (23)
- Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure. (2014) (23)
- South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication (2015) (22)
- Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission (2021) (22)
- Anaemia in Acute HIV-1 Subtype C Infection (2008) (22)
- Placebo controls in HIV perinatal transmission trials: a South African's viewpoint. (1998) (22)
- TRIM5α and TRIM22 Are Differentially Regulated According to HIV-1 Infection Phase and Compartment (2014) (22)
- HIV Superinfection Drives De Novo Antibody Responses and Not Neutralization Breadth (2018) (22)
- Topical Microbicides—What's New? (2013) (21)
- Increased Memory Differentiation Is Associated with Decreased Polyfunctionality for HIV but Not for Cytomegalovirus-Specific CD8+ T Cells (2012) (21)
- Impact of Antiretroviral Therapy on Health-Related Quality of Life among South African Women in the CAPRISA 002 Acute Infection Study (2014) (21)
- HIV-Positive Status Disclosure in Patients in Care in Rural South Africa: Implications for Scaling Up Treatment and Prevention Interventions (2015) (21)
- Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. (2012) (21)
- Individualised Motivational Counselling to Enhance Adherence to Antiretroviral Therapy is not Superior to Didactic Counselling in South African Patients: Findings of the CAPRISA 058 Randomised Controlled Trial (2014) (21)
- Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. (2016) (20)
- Sero-epidemiology of hepatitis A in black South African children. (1993) (20)
- HIV/AIDS in South Africa: The future of the HIV epidemic in South Africa (2010) (20)
- Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women (2017) (19)
- Placebo controls in HIV perinatal transmission trials: a South African's viewpoint. (1998) (19)
- Residual T cell activation and skewed CD8+ T cell memory differentiation despite antiretroviral therapy-induced HIV suppression. (2018) (19)
- Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study (2017) (19)
- High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion. (2002) (19)
- Y Chromosome and HIV DNA Detection in Vaginal Swabs as Biomarkers of Semen and HIV Exposure in Women (2014) (18)
- Apnea and its possible relationship to immunization in ex-premature infants. (2008) (18)
- Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial (2014) (18)
- Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway (2019) (18)
- Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials. (2010) (18)
- Patterns of care in an overburdened tertiary hospital outpatients department. (1990) (18)
- Appropriateness of Hydroxyethylcellulose Gel as a Placebo Control in Vaginal Microbicide Trials: A Comparison of the Two Control Arms of HPTN 035 (2013) (17)
- Limited HIV-1 Superinfection in Seroconverters from the CAPRISA 004 Microbicide Trial (2013) (17)
- Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression (2013) (17)
- Acceptability of a vaginal microbicide among female sex workers (1999) (17)
- Genital—Systemic Chemokine Gradients and the Risk of HIV Acquisition in Women (2017) (17)
- AIDS research must link to local policy (2010) (17)
- Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial (2020) (17)
- Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models (2013) (17)
- Patterns of Infection: Using Age Prevalence and Incidence Data to Understand the Epidemic of HIV in South Africa (2000) (16)
- CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck. (2012) (16)
- Antiretroviral prophylaxis for HIV prevention reaches a key milestone (2012) (16)
- Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women (2016) (16)
- Preservation HIV-1–Specific IFN&ggr;+ CD4+ T-Cell Responses in Breakthrough Infections After Exposure to Tenofovir Gel in the CAPRISA 004 Microbicide Trial (2012) (16)
- Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial. (2014) (16)
- Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis (2021) (16)
- High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa (2014) (16)
- Appropriate names for COVID-19 variants (2021) (16)
- Plasma Cytokine Predictors of Tuberculosis Recurrence in Antiretroviral-Treated Human Immunodeficiency Virus-infected Individuals from Durban, South Africa (2017) (16)
- Replication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression (2017) (15)
- Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV. (2021) (15)
- The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis. (2010) (15)
- Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes (15)
- Sheikh Mujib: triumph and tragedy (2009) (15)
- Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition. (2015) (15)
- Natural killer cell function in women at high risk for HIV acquisition: insights from a microbicide trial (2012) (15)
- Efavirenz Dosing: Influence of Drug Metabolizing Enzyme Polymorphisms and Concurrent Tuberculosis Treatment (2015) (14)
- Ritonavir/saquinavir safety concerns curtail antiretroviral therapy options for tuberculosis-HIV-co-infected patients in resource-constrained settings. (2006) (14)
- Challenges to the control of sexually transmitted diseases in Africa. (1994) (14)
- Microbicides & their implications in HIV prevention (2010) (14)
- Antiretroviral therapy: challenges and options in South Africa (2003) (14)
- Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2015) (14)
- HIV-1 Superinfection Resembles Primary Infection. (2015) (14)
- Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women (2020) (13)
- Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? (2016) (13)
- The microbiome and HIV prevention strategies in women (2018) (13)
- COVID-19 affects HIV and tuberculosis care. (2020) (13)
- Teenagers seeking condoms at family planning services. Part II. A provider's perspective. (1992) (13)
- Short course antiretroviral regimens to reduce maternal transmission of HIV (1999) (13)
- Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women (2017) (13)
- Public-private health sector partnerships for STD control in South Africa--perspectives from the Hlabisa experience. (2001) (13)
- Medical education after the first decade of democracy in South Africa (2004) (12)
- Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials (2010) (12)
- Traditional healers and AIDS prevention. (1993) (12)
- Medical education after the first decade of democracy in South Africa. (2004) (12)
- HIV pre-exposure prophylaxis in injecting drug users (2013) (12)
- Monitoring Microbicide Gel Use with Real-Time Notification of the Container’s Opening Events: Results of the CAPRISA Wisebag Study (2014) (12)
- Utilizing nucleic acid amplification to identify acute HIV infection. (2007) (12)
- Challenges to the control of sexually transmitted diseases in Africa. (1994) (12)
- COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps (2022) (11)
- Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape (2020) (11)
- Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials (2020) (11)
- Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies (2018) (11)
- HIV prevalence among high school learners - opportunities for school-based HIV testing programmes and sexual reproductive health services. (2012) (11)
- Association of TRIM 22 with the Type 1 Interferon Response and Viral Control during Primary HIV-1 Infection (2010) (11)
- No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial (2013) (11)
- HIV Discordance Among Migrant and Non-Migrant Couples in South Africa (2000) (11)
- Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Ad26.CoV2.S Vaccination in People Living With Human Immunodeficiency Virus (HIV) (2021) (11)
- Social Context of Adherence in an Open-Label 1 % Tenofovir Gel Trial: Gender Dynamics and Disclosure in KwaZulu-Natal, South Africa (2016) (11)
- Intersubtype Differences in the Effect of a Rare p24 Gag Mutation on HIV-1 Replicative Fitness (2012) (11)
- Assessing Adherence in the CAPRISA 004 Tenofovir Gel HIV Prevention Trial: Results of a Nested Case–Control Study (2014) (11)
- Microbicides for prevention of HIV infection: clinical efficacy trials. (2014) (11)
- Mannose-rich glycosylation patterns on HIV-1 subtype C gp 120 and sensitivity to the lectins (2011) (11)
- Cost-Effectiveness of Initiating Antiretroviral Therapy at Different Points in TB Treatment in HIV-TB Coinfected Ambulatory Patients in South Africa (2015) (11)
- Traditional healers and AIDS prevention. (1993) (11)
- Assessing the implementation effectiveness and safety of 1% tenofovir gel provision through family planning services in KwaZulu-Natal, South Africa: study protocol for an open-label randomized controlled trial (2014) (11)
- Changes in HIV seroprevalence in a rural black community in KwaZulu. (1992) (11)
- Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation (2018) (10)
- Unsustainability of a measles immunisation campaign--rise in measles incidence within 2 years of the campaign. (1993) (10)
- Antibodies for HIV prevention in young women (2015) (10)
- Impact of a measles immunisation campaign on measles admissions to a Natal hospital. (1991) (10)
- Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract (2019) (10)
- An AIDS-Free Generation? (2012) (10)
- Trends in Cases, Hospitalizations, and Mortality Related to the Omicron BA.4/BA.5 Subvariants in South Africa (2022) (9)
- Association of Polymorphisms in the Regulatory Region of the Cyclophilin a Gene (PPIA) with Gene Expression and HIV/AIDS Disease Progression (2016) (9)
- The Preventive Misconception: Experiences from CAPRISA 004 (2014) (9)
- CAPRISA 018: a phase I/II clinical trial study protocol to assess the safety, acceptability, tolerability and pharmacokinetics of a sustained-release tenofovir alafenamide subdermal implant for HIV prevention in women (2022) (9)
- Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses (2017) (9)
- Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study. (2020) (9)
- TB treatment outcomes following directly-observed treatment at an urban outpatient specialist TB facility in South Africa (2006) (9)
- HIV/AIDS in South Africa: Overview of the book (2010) (9)
- Diminished HIV Infection of Target CD4+ T Cells in a Toll-Like Receptor 4 Stimulated in vitro Model (2019) (9)
- Design challenges facing clinical trials of the effectiveness of new HIV-prevention technologies (2012) (9)
- Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies (2014) (9)
- Clinical decisions. Preexposure prophylaxis for HIV prevention. (2012) (9)
- Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa: study protocol for the CAPRISA 012A randomised controlled phase I trial (2019) (9)
- Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa. (2015) (9)
- Short communication decreased incidence of dual infections in South african subtype C-infected women compared to a cohort ten years earlier. (2011) (9)
- Audio Interview: The Omicron Variant of SARS-CoV-2. (2021) (8)
- Interleukin 1-Beta (IL-1&bgr;) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients (2017) (8)
- Durban 2000 to Toronto 2006: the evolving challenges in implementing AIDS treatment in Africa. (2006) (8)
- Modulation of Female Genital Tract-Derived Dendritic Cell Migration and Activation in Response to Inflammatory Cytokines and Toll-Like Receptor Agonists (2016) (8)
- Hepatitis C virus infection in urban and rural Natal/KwaZulu. (1993) (8)
- Measuring Adherence by Visual Inspection of Returned Empty Gel Applicators in the CAPRISA 004 Microbicide Trial (2014) (8)
- Relationship between Levels of Inflammatory Cytokines in the Genital Tract and CD 4 Cell Counts in Women with Acute HIV-1 Infection (2008) (7)
- Viral hepatitis B--an overview. (1994) (7)
- Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives (2020) (7)
- Is the UNAIDS target sufficient for HIV control in Botswana? (2016) (7)
- Clinical severity of COVID-19 patients admitted to hospitals during the Omicron wave in South Africa (2022) (7)
- Ex vivo HIV entry into blood CD4+ T cells does not predict heterosexual HIV acquisition in women (2018) (7)
- Assessing a diagnosis tool for bacterial vaginosis (2020) (7)
- Diverse approaches useful for microbicide trials (2007) (6)
- Breaking the silence, one year later: reflections on the Durban Conference. (2001) (6)
- Commentary: Spatial clustering of HIV infection: providing clues for effective HIV prevention. (2009) (6)
- Sustainability of task-shifting for antiretroviral treatment (2012) (6)
- Neither Microbial Translocation Nor TLR Responsiveness Are Likely Explanations for Preexisting Immune Activation in Women Who Subsequently Acquired HIV in CAPRISA 004 (2013) (6)
- Natural killer cell function in women at high risk for HIV acquisition: Insights from the CAPRISA004 microbicide trial (2012) (6)
- 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (2015) (5)
- Brief Report: Selection of HIV-1 Variants With Higher Transmission Potential by 1% Tenofovir Gel Microbicide (2017) (5)
- Time to Stop Using Ineffective Covid-19 Drugs. (2022) (5)
- HIV/AIDS in South Africa: New prevention strategies under development and investigation (2010) (5)
- Under-reporting in hepatitis B notifications. (1991) (5)
- Under-reporting in hepatitis B notifications. (1991) (5)
- Commentary: Spatial clustering of HIV infection: providing clues for effective HIV prevention (2009) (5)
- Globalization, Ethics, and AIDS Vaccines (2000) (5)
- HIV incidence estimates are key to understanding the changing HIV epidemic in South Africa. (2007) (5)
- Conserved positive selection signals in gp41 across multiple subtypes and difference in selection signals detectable in gp41 sequences sampled during acute and chronic HIV-1 subtype C infection (2008) (5)
- The Impact of Semen Exposure on the Immune and Microbial Environments of the Female Genital Tract (2020) (5)
- Declining adherence is a more likely explanation than frailty of the apparent decline in efficacy in the CAPRISA 004 trial. (2012) (5)
- Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women (2021) (5)
- ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection (2021) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Impact of point-of-care testing and treatment of sexually transmitted infections and bacterial vaginosis on genital tract inflammatory cytokines in a cohort of young South African women (2021) (4)
- A cluster‐randomized controlled trial to improve the quality of integrated HIV‐tuberculosis services in primary healthcareclinics in South Africa (2021) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Acceptability of a Vaginal Microbicide Among Sex Workers in KwaZulu, Natal, South Africa (1998) (4)
- tuberculosis amongst patients initiating antiretroviral therapy (2013) (4)
- Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. (2021) (4)
- Increasing burden of pulmonary tuberculosis in young women. (2006) (4)
- Public understanding of science: Communicating in the midst of a pandemic (2022) (4)
- Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (2016) (4)
- Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression (2022) (3)
- Betamethasone induces potent immunosuppression and reduces HIV infection in a PBMC in vitro model (2020) (3)
- Putting the records straight--a plea for improved abortion data. (1995) (3)
- No evidence for naturally occurring mutations resistant to HIV-1 reverse-transcriptase inhibitors among South African HIV-1 subtype C isolates (2000) (3)
- CHAPTER 49 – HIV Transmission and its Prevention in Africa (2008) (3)
- What is the best hepatitis B vaccination strategy for South Africa? (1998) (3)
- HIV—No time for complacency (2018) (3)
- Globalization, ethics, and AIDS vaccines. (2000) (3)
- Nelson R. Mandela (1918–2013) (2014) (3)
- Transient association between semen exposure and biomarkers of genital inflammation in South African women at risk of HIV infection (2021) (3)
- Translating Pre-Exposure Prophylaxis Evidence into Practice and Public Health Impact (2014) (3)
- Changes in concentrations of cervicovaginal immune mediators across the menstrual cycle: a systematic review and meta-analysis of individual patient data (2020) (3)
- Response to Brown et al., 'Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe'. (2007) (2)
- Hepatitis B virus in a culicine mosquito species in the RSA. (1986) (2)
- Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention (2022) (2)
- Measuring effectiveness of tuberculosis control programmes. (1997) (2)
- Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET‐EN), in South African women (2021) (2)
- P3.090 Bacterial Vaginosis and the Risk of Trichomonas Vaginalis Acquisition Among HIV-1 Negative Women (2013) (2)
- Safe Sex Practices Among Sex Workers at Risk of HIV Infection (1998) (2)
- Immunological correlates of the HIV-1 replication-competent reservoir size. (2021) (2)
- Vaginal microbial shifts are unaffected by oral pre-exposure prophylaxis in South African women (2022) (2)
- Epigenetic Regulation of BST-2 Expression Levels and the Effect on HIV-1 Pathogenesis (2021) (2)
- Why viral hepatitis? (1994) (2)
- Diverse approaches useful for microbicide trials. (2007) (2)
- Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. (2016) (2)
- Making AIDS a notifiable disease--is it an appropriate policy for South Africa? (1999) (2)
- Making AIDS a notifiable disease--is it an appropriate policy for South Africa? (1999) (2)
- Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes (2021) (2)
- Racial Disparities in HIV Incidence Among Young MSM (2007) (2)
- Mortality in HIV and tuberculosis patients following implementation of integrated HIV-TB treatment: Results from an open-label cluster-randomized trial (2022) (2)
- Challenges in HIV-prevention microbicide research. (2008) (2)
- Low prevalence of delta hepatitis virus infection among blacks in Natal. (1991) (2)
- Early evolution of human leucocyte antigen-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C-infected women (2017) (2)
- Overcoming Impediments to Global Implementation of Early Antiretroviral Therapy. (2015) (2)
- HIV incidence trends in Africa: young women at highest risk. (2021) (2)
- Challenging racial stereotyping of AIDS in South Africa with prevalence of HIV in pregnant women. (2007) (2)
- An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure (2012) (2)
- Rural South African Women and Their Risk for Undetected Sexually Transmitted Diseases and HIV Infection (2000) (2)
- Efficacy and Safety of Tenofovir-Containing Antiretroviral Therapy in Women who Acquired HIV while Enrolled in Tenofovir Gel Prophylaxis Trials (2016) (2)
- PRO 2000: next steps for microbicide development (2009) (2)
- Improving survival with tuberculosis & HIV treatment integration: A mini-review (2019) (2)
- Assessing progress with HIV incidence in national cohorts. (2017) (2)
- Appeal to global donors to save the Treatment Action Campaign (2014) (2)
- TWO DISEASES (TB/HIV) AND TWO MEDICINES (ATT/ART): ONE PATIENT AND ONE SERVICE! (2015) (1)
- Top stories of 2004. DNA-MVA prime boost: another vaccine candidate bites the dust. (2005) (1)
- Prospective study of oral pre‐exposure prophylaxis initiation and adherence among young women in KwaZulu‐Natal, South Africa (2022) (1)
- Recombination-mediated escape from primary CD8+ T cells in acute HIV-1 infection (2014) (1)
- Should AIDS be made notifiable? (1991) (1)
- Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial. (2013) (1)
- Meeting report from the XV International AIDS Conference. Prevention. (2004) (1)
- Report from the XVI International AIDS Conference. SMART and DART: intermittent antiretroviral treatment is suboptimal and should be avoided. (2006) (1)
- Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women (2020) (1)
- An AIDS-Free Generation? (2012) (1)
- Pregnancy rates and outcomes in a longitudinal HIV cohort in the context of evolving antiretroviral treatment provision in South Africa (2022) (1)
- Correction to: Addressing challenges in scaling up TB and HIV treatment integration in rural primary healthcare clinics in South Africa (SUTHI): a cluster randomized controlled trial protocol (2019) (1)
- Higher mucosal antibody concentrations in women with genital tract inflammation (2021) (1)
- Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis (2019) (1)
- Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial (2022) (1)
- Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review (2023) (1)
- Impact of SARS-CoV-2 variants of concern on Covid-19 epidemic in South Africa (2021) (1)
- Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial. (2023) (1)
- The prevention of hepatitis. (1994) (1)
- Occupational disease in a chromate producing factory. (1993) (1)
- Correction to: Integrating and Interpreting Findings from the Latest Treatment as Prevention Trials (2020) (1)
- Top stories of 2008. The prospect of PrEP. (2009) (1)
- COVID-19 in Africa: Catalyzing change for sustainable development (2021) (1)
- Correction for Anthony et al., “Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope” (2018) (1)
- HIV—No time for complacency (2018) (1)
- HIV vaccine and microbicide trials turn a corner. We still don't have an effective vaccine or microbicide for the clinic, but two major trials this year brought us closer than we've ever been. (2010) (1)
- Track C Epidemiology and Prevention Science (2012) (1)
- Underreporting and overreporting of hepatitis B at a tertiary hospital (1997) (1)
- The African Experience (2005) (1)
- Should AIDS be made notifiable (1991) (1)
- Hospital inpatient audit--information for action. (1998) (1)
- Increased differentiation associates with decreased polyfunctionality for HIV but not CMV-specific CD8+ T cell responses (2012) (1)
- Recurrent Subclinical Tuberculosis Among Antiretroviral Therapy–Accessing Participants: Incidence, Clinical Course, and Outcomes (2022) (1)
- The CAPRISA Clinical Trials: HIV Treatment and Prevention (2017) (1)
- Meeting report from the XV International AIDS Conference. Prevention. (2004) (1)
- Antiretrovirals for HIV prevention: new hope and opportunity (2014) (1)
- PLOS Medicine 2017 Reviewer and Editorial Board Thank You (2018) (1)
- Correction: Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization (2017) (1)
- Recent and upcoming advances (2016) (1)
- Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models (2013) (1)
- Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa (2022) (1)
- Scientists stand by decision to join Mbeki's AIDS panel (2009) (1)
- Antiretroviral Rollout in Resource-Constrained Settings: Achievements and Challenges (2012) (1)
- Managing Drug Interactions in the Treatment of HIV-Associated TB (2014) (1)
- The Prospect of PrEP (2008) (1)
- Reviewers for the Journal, January-June 2016. (2016) (1)
- HLA Associations With HIV-1 Seronegative Sex Workers From KwaZulu-Natal, South Africa (2000) (1)
- Microbicides for the Prevention of HIV Infection (2006) (1)
- Closing the NIH Fogarty Center threatens US and global health (2017) (1)
- XDR- and MDR-TB in Rural South Africa Is Caused by Exogenous Reinfection (2008) (1)
- Re: "Enhancement of HIV infection by cellulose sulfate," by Tao et al. (2009) (1)
- Burden of sexually transmitted infections from acute HIV infection among women in South Africa: Evidence from a prospective cohort study. (2022) (1)
- Chapter 39 – Governmental Support of Research (2017) (1)
- Chapter 9 – HIV prevention (2012) (1)
- Comparison of the neutralization sensitivity of South African and Indian HIV-1 subtype C viruses to South African plasma antibodies (2012) (1)
- High Mortality in a South African XDR TB Outbreak (2006) (1)
- Interleukin 1-Beta (IL-1b) Production by Innate Cells Following TLR Stimulation Correlates With TB Recurrence in ART-Treated HIV-Infected Patients (2019) (1)
- Antiretroviral therapy improves survival in patients with HIV and multi-drug resistant tuberculosis (2012) (0)
- Performance of Rapid Antigen Tests in Identifying Omicron Ba.4 and Ba.5 Infections in South Africa (2023) (0)
- Urine-Based Tuberculosis Test in Hospitalized HIV-Positive Patients (2016) (0)
- Improving HIV Diagnosis at Birth to Increase Early ART Initiation (2014) (0)
- Antiretrovirals for HIV Prevention: The CAPRISA 004 Tenofovir Gel Trial (2017) (0)
- Demand for PrEP Is High: Experiences from PrEP Implementation Programs in San Francisco (2014) (0)
- Binding of CAP206-CH12 mAb and CAP206-CH12 RUA to gp41 MPER peptide and gp41-inter protein. (2011) (0)
- Risk Behaviors Among HIV-Positive Individuals (2004) (0)
- Mervyn W. Susser - his contributions to the acquired immune deficiency syndrome response in South Africa. (2014) (0)
- High Rates of Virologic Failure Among Patients on Second-Line ART in Resource-Constrained Settings (2012) (0)
- Functional analyses of Nef clones from treatment and placebo arms. (2013) (0)
- Second-Line ART Regimens for Resource-Limited Settings (2014) (0)
- PEPFAR in Sub-Saharan Africa: Effects on HIV-Related Outcomes (2009) (0)
- Does Pre-Exposure Isoniazid Protect Against TB in HIV-Exposed Children? (2011) (0)
- TMP-SMX Prophylaxis: Don't Let Concern for Antimicrobial Resistance Stop You (2011) (0)
- Audio Interview: Preparing for the Next Pandemic. (2023) (0)
- Men More Likely Than Women to Die While on ART (2012) (0)
- Knowledge of HIV-Positive Status Reduces High-Risk Sexual Behavior (2005) (0)
- Declining HIV Incidence in Uganda Ascribed to Scaled-Up Prevention and Treatment (2017) (0)
- Dolutegravir-Based First-Line Antiretroviral Therapy Seems Safe During Pregnancy (2018) (0)
- Disappointing Results from a Trial of Diaphragm Use for HIV Prevention (2007) (0)
- WHO Criteria Poorly Predict Antiretroviral Treatment Failure (2008) (0)
- Vaccine inequity and hesitancy persist—we must tackle both (2023) (0)
- Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection (cid:1) (2007) (0)
- WHO Updates HIV Treatment Recommendations (2009) (0)
- Cytomegalovirus-Specific CD 8 for HIV but Not for Associated with Decreased Polyfunctionality Increased Memory Differentiation (2012) (0)
- AntibodiesCross-Neutralizing V2-Dependent Multiple Pathways of Escape from HIV (2013) (0)
- Incidence, recurrence, and prevalence of bacterial vaginosis from acute to chronic HIV infection in a prospective cohort of women in South Africa. (2023) (0)
- Antiretroviral pre-exposure prophylaxis; new hope and conundrums. (2012) (0)
- Update on Pre-Exposure Prophylaxis (2011) (0)
- Integrating Prevention into Routine Care (2006) (0)
- HIV-1 Preexposure Prophylaxis (2014) (0)
- Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women. (2017) (0)
- Infection from Southern Africa Individuals with Early Subtype C HIV Type 1 Conserved Regions of Gag Targeted by Novel and Promiscuous CTL Epitopes in (2004) (0)
- Temporal Trends in Global Spending on Health and HIV/AIDS (2018) (0)
- Declining HIV Prevalence in Zimbabwe (2006) (0)
- Education of Religious Leaders Increased Male Circumcision Uptake for HIV Prevention in Tanzania (2017) (0)
- When to Initiate Antiretroviral Therapy in Resource-Poor Settings (2006) (0)
- Duration of Isoniazid Prophylaxis and TB Incidence in HIV-Infected People (2011) (0)
- Report on the XIV International AIDS Conference. (2002) (0)
- ART for HIV/TB-Coinfected Patients Taking Rifampicin: Efavirenz or Nevirapine? (2009) (0)
- PEPFAR Funding Leads to Significant Reductions in Adult Mortality (2012) (0)
- The influence of genetic variation of transportin-SR2 (TNPO3) gene on susceptibility to HIV-1 infection and disease outcomes (2011) (0)
- Next Steps for Tenofovir Gel After the CAPRISA 004 Trial (2011) (0)
- Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda (2017) (0)
- Understanding Anti-HIV Antibody Targets (2010) (0)
- High Risk for Hyperlactatemia and Lactic Acidosis in Women Taking d4T (2007) (0)
- Switching Nevirapine-Exposed, Virologically Suppressed Children to an Efavirenz-Based Antiretroviral Regimen (2015) (0)
- JAMA Internal Medicine Peer Reviewers in 2017. (2018) (0)
- Additional file 3: Figure S2. of Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2016) (0)
- Science Magazine (2008) (0)
- Accumulating resistance of CAP257 clones to broadly neutralizing monoclonal antibodies targeting V2 and the CD4bs. (2013) (0)
- Set Point T Cell Responses on HIV + HIV-Specific CD8 Polyfunctional Capacity, and Specificity of Differential Impact of Magnitude, (2014) (0)
- Improving HIV Self-Testing Among Male Partners of Pregnant Women in Malawi (2019) (0)
- ART to Decrease MTCT and Improve Survival in Botswana (2013) (0)
- Diagnosing HIV Infection During Healthcare Visits: Can We Do Better? (2013) (0)
- required for licensure An adaptive design to bridge the gap between Phase 2 b / 3 microbicide effectiveness trials and evidence (2012) (0)
- CAPRISA: Establishing a Research Centre to Undertake HIV Clinical Trials (2017) (0)
- HIV PrEP Trial in Women Halted (2011) (0)
- FACULTY OF HEALTH SCIENCES UCT (2011) (0)
- Should global financing be the main priority for pandemic preparedness? (2021) (0)
- How HIV Performs Under Stress (2005) (0)
- New Microbicide Blocks HIV Transmission in Macaques (2004) (0)
- Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for CMV-specific CD 8 + T cells (2012) (0)
- Topical formulations antivirals for prevention of transmission of HSV-2 (2011) (0)
- Fluidity of HIV-1 Specific T Cell Responses during Acute and Early Subtype C HIV-1 Infection and Subsequent Disease Progression (2010) (0)
- Report from the Tenth Retrovirus Conference. Vaccines and microbicides. (2003) (0)
- CAPRISA 003: Timing of Antiretroviral Initiation in HIV-TB Co-infected Patients—The SAPiT Trial (2017) (0)
- Dual HIV and Malaria Infection Potentiates the Spread of Both Diseases (2007) (0)
- HIV pre-exposure prophylaxis implementation in Africa: some early lessons (2021) (0)
- Frequent Virologic Monitoring Limits NRTI and NNRTI Resistance (2012) (0)
- The Cost-Effectiveness of Expanding Prevention Programs (2006) (0)
- Studies on multiply exposed but persistently HIV-1 seronegative sex workers from KwaZulu/Natal, South Africa (2000) (0)
- Improved Survival with Multiple Antimicrobial Prophylaxis in Severely Immunosuppressed Patients Initiating ART (2017) (0)
- Salim "Slim" Abdool Karim: attacking AIDS in South Africa. Interview by Amy Maxmen. (2009) (0)
- Scaling up TB-HIV Integration in Public Health Clinics: Translating Research Findings into Practice (2017) (0)
- Is Elimination of a Generalized HIV Epidemic Possible (2008) (0)
- How Prevalent Is CXCR4 Tropism in Treatment-Experienced Patients? (2006) (0)
- Can Behavioral Interventions Improve HIV Treatment Adherence and Viral Control (2011) (0)
- Nutritional Supplements Before ART Eligibility Delay CD4-Cell Decline (2013) (0)
- Integrase Inhibitor Effective in an Animal Model (2004) (0)
- Sexual Risk Behavior in HIV Vaccine Efficacy Trials (2005) (0)
- Prevention Efforts: Good News and Bad (2005) (0)
- E-107 Advancing global health: Lessons from the response to the HIV epidemic (2016) (0)
- In fl ammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection (2016) (0)
- HIV-1-Uninfected Adults Vaccine in Healthy gag HIV-1 Subtype C Evaluations of an Alphavirus Replicon Phase I Safety and Immunogenicity (2012) (0)
- XDR TB: A Growing Public Health Concern (2006) (0)
- Blacks Continue to Bear a Disproportionate Burden of HIV/AIDS in the U.S. (2007) (0)
- HIV/AIDS in South Africa: Introduction (2010) (0)
- Additional file 4: Figure S3. of Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2016) (0)
- Antiretroviral Therapy Uptake by Eligible Individuals Needs To Be Improved (2011) (0)
- Viral-Attachment and Entry Inhibitors Show Promise for Prevention in Monkey Models (2006) (0)
- S17.2 Hpv infection, genital inflammation, and hiv risk in the caprisa 004 trial (2015) (0)
- ACCEPTABILITY OF A VAGINAL MICROBICIDE AMONG FEMALE (1999) (0)
- Optimising the accuracy of HIV drug resistance assays. (2018) (0)
- Improved survival in multi-drug resistant tuberculosis patients receiving integrated TB and ART in the SAPiT Trial (2016) (0)
- Mervyn W. Susser – His Contributions to the Acquired Immune Deficiency Syndrome Response in South Africa (2014) (0)
- Growing HIV Epidemic in China Among MSM (2009) (0)
- Comment on: Enhancement of HIV Infection by Cellulose Sulfate, by Tao et al (2009) (0)
- TB Prophylaxis in HIV-Infected Adults: Stick with the WHO Recommendations (2011) (0)
- HIV/AIDS Susceptibility Is Influenced by the Number of (2005) (0)
- HIV Drug Resistance Is Common After Treatment Failure (2016) (0)
- The Association of Metabolic Syndrome with Alcohol Consumption among Urban Chinese Pro-Alcohol-Use Social Environment and Alcohol Use among Female Sex Workers in China: Beyond the Effects of Serving Alcohol Preparing for National Implementation of an Evidence-based, Effective HIV Prevention Program (2012) (0)
- Intravaginal Substance Use and Douching Practices Among Sex Workers in South Africa: Implications for Microbicide Use (1998) (0)
- Is there a cure for AIDS? (1996) (0)
- Evaluation of training of trainers (TOT) for traditional birth attendants training. (1994) (0)
- 9.13 Acquired immunodeficiency syndrome (2009) (0)
- E-106 The Global HIV Epidemic: Prospects and Challenges (2014) (0)
- Patients on Suppressive ART Can Transmit HIV Infection (2008) (0)
- Acquired immunodefi ciency syndrome (2009) (0)
- Additional file 6: Figure S4. of Killer-cell Immunoglobulin-like Receptor (KIR) gene profiles modify HIV disease course, not HIV acquisition in South African women (2016) (0)
- Beneficial HLA-mediated viral polymorphisms on the transmitted virus additively influence disease progression in HIV-1, subtype C infection (2012) (0)
- The Effect of Oscillating Male Migration on Rural South African Women's Health: Implications for Sexually Transmitted Diseases and HIV/AIDS (2000) (0)
- The world facing Covid-19: The African perspective (2021) (0)
- Variable Dependence on Glycan Recognition within a Lineage of V1V2-directed HIV Neutralizing Antibodies (2014) (0)
- Association of Morbidity Among Children with Housing, Water and Sanitation in Urban India: A Policy Perspective (2021) (0)
- Prolonged Co-trimoxazole Is Beneficial for Children on ART in Sub-Saharan Africa (2014) (0)
- Sexually Transmitted Infections and Spousal Violence: The Experience of Married Women in India (2018) (0)
- Routine Laboratory Monitoring Not Essential for Implementation of First-Line ART in Africa (2010) (0)
- CROSS BORDERING STUDIES AMONG DECISION MAKING AND SPOUSAL VIOLENCE IN INDIA AND BANGLADESH (2015) (0)
- Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation (2018) (0)
- Acquired immunodeficiency syndrome (AIDS) (2021) (0)
- Nelson R. Mandela (1918–2013) (2014) (0)
- Academic health complexes--ivory towers or national resources? (1993) (0)
- HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing Antibodies (2022) (0)
- Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression (2022) (0)
- Building on Pasteur's legacy: producing vaccines in Africa (2022) (0)
- The Ongoing Search for New Prevention Technologies (2010) (0)
- ART and pregnancy rates. (2010) (0)
- Individualsin HLA-B*58:01-Positive Associated with HIV-1 Differential Disease Virological and Immunological Factors (2011) (0)
- Assessing a diagnosis tool for bacterial vaginosis (2020) (0)
- Long COVID: a review and proposed visualization of the complexity of long COVID (2023) (0)
- Genital immune cell activation and tenofovir gel efficacy: a case-control study. (2022) (0)
- A1 The role of virus-antibody co-evolution in the development of a V3-glycan-directed HIV-1 broadly neutralizing antibody lineage (2019) (0)
- Plasma Biomarkers of Risk of Tuberculosis Recurrence in HIV Co-Infected Patients From South Africa (2021) (0)
- TMP-SMX prophylaxis reduces mortality among African patients on ART. (2010) (0)
- Acute Pre-seroconversion HIV Infection at Baseline Prior to Starting Oral or Topical Pre-Exposure Prophylaxis: iPrEx and CAPRISA 004 (2010) (0)
- Tenofovir Gel to Prevent HSV-2 Infection. (2015) (0)
- What Does the Future Hold for CAPRISA (2017) (0)
- Should Efavirenz Be Dosed Higher When Coadministered with Rifampin (2012) (0)
- Tenofovir Intravaginal Ring Protects Against SHIV Challenge in Macaques (2013) (0)
- Update on pre-exposure prophylaxis. (2011) (0)
- Perspective conducting HIV prevention research in South Africa. (2008) (0)
- Community-Based Universal HIV Testing and Treatment (2017) (0)
- Advancing HIV prevention using tenofovir-based pre-exposure prophylaxis (2022) (0)
- Does Raising Awareness of HIV Serostatus Lower HIV Incidence (2008) (0)
- SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual (2022) (0)
- The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis (2011) (0)
- Impact of the political violence in Natal on emergency surgical services of a tertiary hospital. (1991) (0)
- PEPFAR Activities Have a Beneficial Effect on Overall Health Outcomes (2013) (0)
- How Common Is HIV Superinfection (2008) (0)
- A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies (2017) (0)
- Structural Constraints of V accine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting (2015) (0)
- Declining HIV Drug Resistance in Europe (2013) (0)
- Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies (2022) (0)
- Phase II study to assess the impact of intermittent 1% Tenofovir Gel on Hepatitis B virus (HBV) infection (2011) (0)
- South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication (2015) (0)
- Special Collection: A pioneer in antiviral drug discovery and development: Commemorating John Martin-Review (2022) (0)
- Rationalisation of data collection for a child health service. (1996) (0)
- High Adherence Critical to the Success of PrEP (2012) (0)
- Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women (2020) (0)
- Obituary: Gita Ramjee (8 April 1956–31 March 2020) (2020) (0)
- Procede de selection d'isolats de sous-type c du vih-1, isolats de sous-type c du vih-1 selectionnes, genes, modifications et derives (2001) (0)
- Vulnerable Sites on the HIV Envelope for Antibody Neutralization (2007) (0)
- Drug Resistance Is Unlikely to Increase Substantially from Use of ART Prevention Strategies (2013) (0)
- P06.13 Inflammatory cytokine biomarkers identify women with asymptomatic genital infections that increase the risk of hiv infection (2015) (0)
- Microbicides: New hope for hiv prevention (2012) (0)
- Six decades of struggle over the pill (2017) (0)
- The Vaginal Microbiome Is Associated with Susceptibility to HIV Infection (2018) (0)
- COVID-19: The Challenge of Global Vaccine Inequity (2023) (0)
- Recommendations for Integrating Prevention into Routine Care of HIV-Positive Patients (2004) (0)
- ART for All HIV-Infected Pregnant Women in Malawi Increases Treatment Coverage (2013) (0)
- Virologic Failure Rates Vary Substantially Across Countries in Africa and Asia (2013) (0)
- Daily Tenofovir-Containing PrEP Ineffective Among Women in Africa Due to Low Adherence (2015) (0)
- Chapter 2 Translating Pre-Exposure Prophylaxis Evidence into Practice and Public Health Impact (2019) (0)
- Impact of Neutralizing Antibodies on Viral Rebound Following Treatment Interruption (2005) (0)
- Antiretroviral Therapy and Life Expectancy in Rural South Africa (2017) (0)
- Omicron infection enhances Delta antibody immunity in vaccinated persons (2022) (0)
This paper list is powered by the following services:
Other Resources About Salim Abdool Karim
What Schools Are Affiliated With Salim Abdool Karim?
Salim Abdool Karim is affiliated with the following schools:
